Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Petros Pharmaceuticals Inc (NQ: PTPI ) 0.4161 +0.0066 (+1.61%) Streaming Delayed Price Updated: 3:50 PM EDT, Jun 20, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 402,168 Open 0.4195 Bid (Size) 0.4149 (3) Ask (Size) 0.4172 (6) Prev. Close 0.4095 Today's Range 0.3950 - 0.4300 52wk Range 0.3850 - 4.740 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News EXCLUSIVE: 'Prescription Erectile Dysfunction Market Could Triple If an ED Therapy Is Made Available OTC,' Petros Pharma President Says June 17, 2024 Petros Pharmaceuticals specializes in men's health therapeutics. President Fady Boctor discusses the company's strategy to make key prescription medications. Petros is poised to expand within the $66.5... Via Benzinga Why Signet Jewelers Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session June 13, 2024 Via Benzinga Performance YTD -70.70% -70.70% 1 Month -33.41% -33.41% 3 Month -70.49% -70.49% 6 Month -69.40% -69.40% 1 Year -81.83% -81.83% More News Read More 12 Health Care Stocks Moving In Thursday's Intraday Session June 13, 2024 Via Benzinga Petros Pharmaceuticals Activates Advisory Committee to Help Guide Rx-to-OTC Switch for STENDRA May 21, 2024 Via ACCESSWIRE Petros Pharmaceuticals Receives Positive Response from FDA Following Recent Demonstration of Technology Component in Pursuit of OTC Status for STENDRA(R) (avanafil) April 16, 2024 Via ACCESSWIRE Petros Pharmaceuticals Enters into AI Licensing Agreement with Leading Multi-Billion-Dollar Software Provider February 14, 2024 Via ACCESSWIRE Why Broadcom Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket June 13, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session June 13, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday June 13, 2024 Via InvestorPlace 12 Health Care Stocks Moving In Wednesday's After-Market Session May 29, 2024 Via Benzinga Petros Pharmaceuticals Successfully Completes AI-Integrated Formative Human Factors Study Demonstrating Positive Interaction with Web App Designed for STENDRA(R) (avanafil) OTC Switch May 29, 2024 Via ACCESSWIRE PTPI Stock Earnings: Petros Pharmaceuticals Misses EPS, Misses Revenue for Q1 2024 May 16, 2024 Via InvestorPlace 12 Health Care Stocks Moving In Wednesday's After-Market Session May 15, 2024 Via Benzinga Lemonaid Health Now Offers Prescription ED Medication STENDRAⓇ Through Collaboration with Petros Pharmaceuticals May 14, 2024 From 23andMe, Inc. Via GlobeNewswire Petros Pharmaceuticals Launches U.S. Distribution of Prescription ED Medication STENDRA Through Recently Announced Collaboration With Lemonaid Health, a Subsidiary of 23andMe May 14, 2024 Via ACCESSWIRE Petros Pharmaceuticals Expands Online Distribution for Prescription STENDRA(R) (avanafil) Through New Agreement with Lemonaid Health April 23, 2024 Via ACCESSWIRE Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session April 02, 2024 Via Benzinga PTPI Stock Earnings: Petros Pharmaceuticals Misses EPS, Misses Revenue for Q4 2023 April 02, 2024 Via InvestorPlace 12 Health Care Stocks Moving In Tuesday's Pre-Market Session April 02, 2024 Via Benzinga Petros Pharmaceuticals Reports Positive Results in an Initial Cohort Two-Arm Self-Selection (Phase 2-Equivalent) Study for STENDRA(R) (avanafil) as it Pursues OTC Status April 02, 2024 Via ACCESSWIRE Petros Pharmaceuticals Successfully Launches AI Tool In Collaboration with Multi-Billion-Dollar Software Provider March 19, 2024 Via ACCESSWIRE BestGrowthStocks.Com Issues Comprehensive Analysis of Petros Pharmaceuticals Inc March 11, 2024 Via TheNewswire.com Exposures Product Safety BestGrowthStocks.Com Issues Comprehensive Analysis of Petros Pharmaceuticals Inc March 11, 2024 Via News Direct Exposures Product Safety 12 Health Care Stocks Moving In Tuesday's After-Market Session January 30, 2024 Via Benzinga Why UPS Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session January 30, 2024 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
